Agreed. Current leadership is no good so what are the options...
1 - Same management (all this talk about removing the board sounds great but how likely is it really?)
2 - Change in management... these incoming staff have little experience in the company and whilst we all hope for a smooth transition; time and money are both factors that can't be ignored. We also have no inkling as to the competence of these new people so it's another gamble.
How many times have great products/innovations/companies been euthanised by their own leadership's lack of foresight? The majority of holders who invested early on believed in the tech but too many mistakes have been made by the powers that be.
If we get tier 1 people (proven biotech track record, vast experience, expansive networks to tap into); this thing can get off the ground again but how likely is this scenario?
RAP Price at posting:
18.5¢ Sentiment: None Disclosure: Held
